Status:

COMPLETED

Endoscopic Stenting of Gastrointestinal Cancer

Lead Sponsor:

Ullevaal University Hospital

Conditions:

Gastrointestinal Neoplasms

Biliary Tract Neoplasms

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Obstruction of the digestive tract is a frequent cause of morbidity in patients with gastrointestinal cancer.Palliative endoscopic treatment with self- expanding metal stents(SEMS)is an alternative to...

Detailed Description

The study is divided into four projects: 1. Establish a central register over all patients with malignant GI-obstruction who are treated with SEMS in the Eastern health region in Norway .Treatment in...

Eligibility Criteria

Inclusion

  • Palliative SEMS treatment for malignant GI-obstruction in esophagus,gastroduodenal region, biliary tractus or colon
  • SEMS treatment of acute malignant colon obstruction as a bridge to surgery

Exclusion

  • Not able to sign informed consent
  • SEMS placement in other location last 4 days

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2010

Estimated Enrollment :

270 Patients enrolled

Trial Details

Trial ID

NCT00422409

Start Date

October 1 2006

End Date

April 1 2010

Last Update

July 6 2011

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Sentral Hospital Buskerud

Drammen, Norway

2

Sentral Hospital Østfold

Fredrikstad, Norway

3

Sykehuset Innlandet Gjøvik

Gjøvik, Norway

4

Sykehuset Innlandet Lillehammer

Lillehammer, Norway

Endoscopic Stenting of Gastrointestinal Cancer | DecenTrialz